Gary Soucie
Family Medicine · Blackfoot, IDNPI 1255386082
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Eli Lilly accounts for 73.7% of it on its own, with 41 other manufacturers making up the rest. Reporting peaked in 2023 at $18,485 and has fallen 96.1% since, to $724 in 2025. Among family medicine clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 464 payments — averaging $79.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$27K
- Lilly USA, LLC$5K
- AbbVie$1K
- Novo Nordisk$473
- Amgen$449
- Astellas Pharma US Inc$350
- plus $2K from 36 others
Across 773 payments — averaging $7521.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$4.1M
- Pfizer$411K
- Supernus Pharmaceuticals, Inc.$387K
- Romark Laboratories, LC$281K
- Regeneron$195K
- Sanofi Pasteur Inc.$162K
- plus $280K from 4 others
What the payments were for
- Consulting fees$9,60026%
- Travel & lodging$19,71354%
- Food & beverage$7,27120%
- Education$2031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$36,787 in reported general payments places this provider in the 95th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 174 | $195,341 |
| EliquisApixaban | 110 | $80,163 |
| MounjaroTirzepatide | 60 | $69,623 |
| JardianceEmpagliflozin | 52 | $61,697 |
| LinzessLinaclotide | 52 | $40,335 |
| Tresiba Flextouch U-200Insulin Degludec | 37 | $33,435 |
| TrulicityDulaglutide | 28 | $32,915 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $31,929 |
| VraylarCariprazine Hcl | 22 | $30,524 |
| RybelsusSemaglutide | 15 | $24,203 |
| Nurtec OdtRimegepant Sulfate | 18 | $21,897 |
| FarxigaDapagliflozin Propanediol | 25 | $19,682 |
| UbrelvyUbrogepant | 16 | $18,755 |
| Tresiba Flextouch U-100Insulin Degludec | 34 | $17,757 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 12 | $16,901 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $473 | $222,194202 claims |
| Lilly USA, LLCMounjaro, Trulicity | $4,578 | $102,53888 claims |
| PfizerEliquis, Nurtec Odt | $296 | $102,060128 claims |
| AbbVieLinzess, Vraylar, Ubrelvy | $1,364 | $89,61490 claims |
| Boehringer IngelheimJardiance | $140 | $61,69752 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $188 | $38,76254 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $74 | $31,40043 claims |
| MerckJanuvia | $64 | $16,50716 claims |
| Johnson & JohnsonXarelto | $153 | $16,30515 claims |
| Astellas Pharma US IncMyrbetriq | $350 | $13,26228 claims |
| NovartisEntresto | $88 | $10,41014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 803 family medicine providers in Idaho.
Other family medicine in Blackfoot
- Paul BeckettBlackfoot$17K
- Matthew FackrellBlackfoot$5K
- Kenneth CongerSandpoint$266K
- David ButukMeridian$206K
- Anne BroadwayIdaho Falls$184K
- Timothy McHughMeridian$165K
- Phyllis YouBoise$88K
- Ralph SutherlinSt Maries$73K
- Henry DownsCoeur D Alene$69K
- Crystal PyrakCoeur D Alene$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.